Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2025-05-12 11:33:15
Reference is made to the stock exchange release published by Arctic Bioscience 8th May 2025 regarding Board approval of share capital increase related to the exercise of debt conversion rights and corresponding issuance of new shares in Arctic Bioscience.
The share capital increase has now been registered with the Norwegian Register of Business Enterprises. As a result, the new share capital of Arctic Bioscience has increased from NOK 2 668 934 to NOK 2 685 934, divided into 26 859 340 shares, each having a nominal value of NOK 0,10.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Act.